Benzinga | Aug 14, 2020 09:34AM EDT

Trevi Therapeutics Yesterday Reported Q2 EPS $(0.41) Up From $(0.63) YoY

Trevi Therapeutics (NASDAQ:TRVI) reported quarterly losses of $(0.41) per share. This is a 34.92 percent increase over losses of $(0.63) per share from the same period last year.